Latest Breaking News On - Howardc herrmann - Page 1 : comparemela.com

Medtronic TAVR Outcomes from SMART Trial and Optimize PRO Addendum on Evolut TAVR Presented at SCAI 2024 Scientific Sessions

Medtronic has more positive transcatheter heart valve data

Medtronic (NYSE: MDT) today announced the release of new data for its transcatheter heart valve therapy technologies.

For Small Annuli, Self-Expanding TAVR May Have an Advantage

A head-to-head trial of two widely used TAVR devices in patients with small aortic annuli, mostly women, showed differences in performance at 1 year in the SMART trial.

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

First head-to-head comparison of leading valve types finds better valve performance with selfexpanding valve and non-inferior clinical outcomes at one year

In small aortic annuli, self-expanding TAVR valve may be preferred for hemodynamics